Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VTI1BP4 is classified as a human pseudogene closely related to VTI1B, a gene encoding a vesicular SNARE protein involved in intracellular membrane trafficking, particularly at late endosomes and the Golgi network. Pseudogenes are genome sequences similar to known genes but regarded as non-functional, typically failing to produce active proteins due to mutations, deletions, or lack of regulatory elements. There is no known data supporting VTI1BP4 expression as a functional molecule, nor any established biological function, clinical significance, or role as a drug target. It is not considered a therapeutic target as there is no evidence it encodes any functional molecule, or acts as a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vesicle transport through interaction with t-SNAREs homolog 1B pseudogene 4 (VTI1BP4).